Abstract
Genetic inactivation of key components of the Wnt signal transduction system is a frequent event in colorectal cancer. These genetic mutations lead to stabilization of β-catenin, a cytoplasmic–nuclear shuttling protein with a potent transcription activation domain. Stabilization and subsequent nuclear localization of β-catenin produces aberrant, Wnt-independent signals to target genes, an activity tightly linked to the genesis of colon cancers. In the nucleus, the transcription factor family of LEF/TCF proteins transmits Wnt signals by binding to β-catenin and recruiting it to target genes for activation. Such activities are carried out by full-length LEF/TCFs that are thought to be mostly interchangeable and redundant. However, truncated forms of LEF-1 and TCF-1 that do not bind to β-catenin function as dominant negatives and an alternatively spliced TCF isoform with a unique activation function has recently been discovered. The dominant negative forms block Wnt signals because they occupy Wnt target genes and limit β-catenin access; the alternatively spliced TCF isoform activates certain Wnt target promoters whereas other TCF isoforms and LEF-1 do not. A study of LEF/TCF expression and activity in normal intestine and colon carcinomas suggests that the relative amounts of LEF/TCF isoforms may change as tumors progress and this may influence the strength and specificity of Wnt signals in the nucleus. While the underlying mechanism for a change in the LEF/TCF isoform expression is not yet known, recent evidence implicates the Wnt signaling pathway itself as a potential modulator.
Similar content being viewed by others
References
Polakis P: Wnt signaling and cancer. Genes Dev. 14: 1837–1851, 2000
Peifer M, Polakis P: Wnt signaling in oncogenesis and embryogenesis-a look outside the nucleus. Science 287: 1606–1609, 2000
Taipale J, Beachy PA: The Hedgehog and Wnt signaling pathways in cancer. Nature 411: 349–354, 2001
Bienz M, Clevers H: Linking colorectal cancer to Wnt signaling. Cell 103: 311–320, 2000
Groden J: Touch and go: Mediating cell-to-cell interactions and Wnt signaling in gastrointestinal tumor formation. Gastroenterology 119: 1161–1164, 2000
Barker N, Clevers H: Catenins, Wnt signaling and cancer. BioEssays 22: 961–965, 2000
Moon RT, Bowerman B, Boutros M, Perrimon N: The promise and perils of Wnt signaling through beta-catenin. Science 296: 1644–1646, 2002
Henderson BR, Fagotto F: The ins and outs of APC and ta-catenin nuclear transport. EMBO Rep 3: 834–839, 2002
Woodgett J: Regulation and functions of the glycogen synthase kinase-3 subfamily. Sem. Cancer Biol 5: 269–275, 1994
Cook D, Fry M, Hughes K, Sumathipala R, Woodgett J, Dale T: Wingless inactivates glycogen synthase kinase-3 via an intracellular signaling pathway which involves a protein kinase C. Embo J 15: 4526–4536, 1996
Harwood AJ: Regulation of GSK-3: A cellular multi-processor. Cell 105: 821–824, 2001
Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737, 1993
Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, Munemitsu S, Polakis P: Association of the APC gene product with beta-catenin. Science 262: 1731–1734, 1993
Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, Lee JJ, Tilghman SM, Gumbiner BM, Costantini F: The mouse fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 90: 181–192, 1997
Behrens J, Jerchow B-A, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhn M, Wedlich D, Birchmeier W: Functional interaction of an axin homolog, conductin, with β-catenin, APC and GSK3β. Science 280: 596–599, 1998
Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, Zhang Z, Lin X, He X: Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108: 837–847, 2002
Amit S, Hatzubai A, Birman Y, Andersen JS, Ben-Shushan E, Mann M, Ben-Neriah Y, Alkalay I: Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: A molecular switch for the Wnt pathway. Genes Dev 16: 1066–1076, 2002
Hart MJ, de los Santos R, Albert IN, Rubinfeld B, Polakis P: Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 8: 573–581, 1998
Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 17: 1371–1384, 1998
Sakanaka C, Leong P, Xu L, Harrison SD, Williams LT: Casein kinase iepsilon in the wnt pathway: Regulation of beta-catenin function. Proc Natl Acad Sci USA 96: 12548–12552, 1999
Sakanaka C, Weiss JB, Williams LT: Bridging of betacatenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci USA 95: 3020–3023, 1998
von Kries JP, Winbeck G, Asbrand C, Schwarz-Romond T, Sochnikova N, Dell'Oro A, Behrens J, Birchmeier W: Hot spots in beta-catenin for interactions with LEF-1, conductin and APC. Nat Struct Biol 7: 800–807, 2000
van Noort M, Clevers H: TCF transcription factors, mediators of Wnt-signaling in development and cancer. Dev Biol 244: 1–8, 2002
Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H: Beta-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell, 111: 251–263, 2002
van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R, Clevers H: The beta-Catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241–250, 2002
Brown AM: Wnt signaling in breast cancer: Have we come full circle? Breast Cancer Res 3: 351–355, 2001
Aoki M, Hecht A, Kruse U, Kemler R, Vogt PK: Nuclear endpoint of Wnt signaling: Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc Natl Acad Sci USA 96: 139–144, 1999
Chan EF, Gat U, McNiff JM, Fuchs E: A common human skin tumor is caused by activating mutations in betacatenin. Nat Genet 21: 410–413, 1999
Gat U, DasGupta R, Degenstein L, Fuchs E: De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95: 605–614, 1998
Xu L, Corcoran RB, Welsh JW, Pennica D, Levine AJ: WISP-1 is a Wnt-1-and beta-catenin-responsive oncogene. Genes Dev 14: 585–595, 2000
Tao W, Pennica D, Xu L, Kalejta RF, Levine AJ: Wrch-1, a novel member of the Rho gene familythat is regulated by Wnt-1. Genes Dev 15: 1796–1807, 2001
Kioussi C, Briata P, Baek SH, Rose DW, Hamblet NS, Herman T, Ohgi KA, Lin C, Gleiberman A, Wang J, Brault V, Ruiz-Lozano P, Nguyen HD, Kemler R, Glass CK, Wynshaw-Boris A, Rosenfeld MG: Identification of a Wnt/Dvl/beta-Catenin ? Pitx2 pathwaymediating cell-type-specific proliferation during development. Cell 111: 673–685, 2002
Ishitani T, Ninomiya-Tsuji J, Nagai S, Nishita M, Meneghini M, Barker N, Waterman M, Bowerman B, Clevers H, Shibuya H, Matsumoto K: The TAK1-NLK-MAPK-related pathwayantagonizes signaling between beta-catenin and transcription factor TCF. Nature 399: 798–802, 1999
Snider L, Thirlwell H, Miller JR, Moon RT, Groudine M, Tapscott SJ: Inhibition of Tcf3 binding by I-mfa domain proteins. Mol Cell Biol 21: 1866–1873, 2001
Tago K, Nakamura T, Nishita M, Hyodo J, Nagai S, Murata Y, Adachi S, Ohwada S, Morishita Y, Shibuya H, Akiyama T: Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. Genes Dev 14: 1741–1749, 2000
Sampson EM, Haque ZK, Ku MC, Tevosian SG, Albanese C, Pestell RG, Paulson KE, Yee AS: Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1. EMBO J 20: 4500–4511, 2001
Hatini V, Bokor P, Goto-Mandeville R, DiNardo S: Tissue-and stage-specific modulation of Wingless signaling bythe segment polarity gene lines. Genes Dev 14: 1364–1376, 2000
Zorn AM, Barish GD, Williams BO, Lavender P, Klymkowsky MW, Varmus HE: Regulation of Wnt signaling bySox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin. Mol Cell 4: 487–498, 1999
Kramps T, Peter O, Brunner E, Nellen D, Froesch B, Chatterjee S, Murone M, Zullig S, Basler K: Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex. Cell 109: 47–60, 2002
Parker DS, Jemison J, Cadigan KM: Pygopus, a nuclear PHD-finger protein required for Wingless signaling in Drosophila. Development 129: 2565–2576, 2002
Thompson B, Townsley F, Rosin-Arbesfeld R, Musisi H, Bienz M: A new nuclear component of the Wnt signaling pathway. Nat Cell Biol 4: 367–373, 2002
Belenkaya TY, Han C, Standley HJ, Lin X, Houston DW, Heasman J: Pygopus encodes a nuclear protein essential for wingless/Wnt signaling. Development 129: 4089–4101, 2002
Waterman ML, Fischer WH, Jones KA: A thymus-specific member of the HMG protein family regulates the human T cell receptor C alpha enhancer. Genes Dev 5: 656–669, 1991
Travis A, Amsterdam A, Belanger C, Grosschedl R: LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor alpha enhancer function. Genes Dev 5: 880–894, 1991
van de Wetering M, Oosterwegel M, Dooijes D, Clevers H: Identification and cloning of TCF-1, a T lymphocyte specific transcription factor containing a sequence-specific HMG box. EMBO J 10: 123–132, 1991
Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G, Markman M, Lamers W, Destree O, Clevers H: Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 18: 1248–1256, 1998
Oosterwegel M, van de Wetering M, Timmerman J, Kruisbeek A, Destree O, Meijlink F, Clevers H: Differential expression of the HMG box factors TCF-1 and LEF-1 during murine embryogenesis. Development 118: 439–448, 1993
Reya T, O'Riordan M, Okamura R, Devaney E, Willert K, Nusse R, Grosschedl R: Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism. Immunity 13: 15–24, 2000
Zhou P, Byrne C, Jacobs J, Fuchs E: Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev 9: 700–713, 1995
chanMerrill BJ, Gat U, DasGupta R, Fuchs E: Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 15: 1688–1705, 2001
Hovanes K, Li TW, Munguia JE, Truong T, Milovanovic T, Lawrence Marsh J, Holcombe RF, Waterman ML: Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 28: 53–57, 2001
Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H: Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science 285: 1923–1926, 1999
Porfiri E, Rubinfeld B, Albert I, Hovanes K, Waterman M, Polakis P: Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene 15: 2833–2839, 1997
Barker N, Huls G, Korinek V, Clevers H: Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol 154: 29–35, 1999
Bustin M, Reeves R: High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 54: 35–100, 1996
Giese K, Amsterdam A, Grosschedl R: DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1. Genes Dev 5: 2567–2578, 1991
Giese K, Cox J, Grosscheldl R: The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185–196, 1992
van de Wetering M, Clevers H: Sequence-specific interaction of the HMG box proteins TCF-1 and SRY occurs within the minor groove of a Watson-Crick double helix. EMBO J 11: 3039–3044, 1992
van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A, Peifer M, Mortin M, Clevers H: Armadillo coactivates transcription driven bythe product of the Drosophila segment polaritygene dTCF. Cell 88: 789–799, 1997
Love JJ, Li X, Case DA, Giese K, Grosschedl R, Wright PE: Structural basis for DNA bending by the architectural transcription factor LEF-1. Nature 376: 791–795, 1995
Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H: XTCF-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell 86: 391–399, 1996
Behrens J, von Kries JP, Kuh M, Bruhn L, Wedlich D, Grosschedl R, Birchmeier W: Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638–642, 1996
Brunner E, Peter O, Schweizer L, Basler K: Pangolin encodes a LEF-1 homologue that acts downstream of Armadillo to transduce the Wingless signal in Drosophila. Nature 385: 829–833, 1997
Graham TA, Ferkey DM, Mao F, Kimelman D, Xu W: Tcf4 can specifically recognize beta-catenin using alternative conformations. Nat Struct Biol 8: 1048–1052, 2001
Graham TA, Weaver C, Mao F, Kimelman D, Xu W: Crystal structure of a beta-catenin/Tcf complex. Cell 103: 885–896, 2000
van de Wetering M, Castrop J, Korinek V, Clevers H: Extensive alternative splicing and dual promoter usage generate Tcf-protein isoforms with differential transcription control properties. Mol Cell Biol 16: 745–752, 1996
Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R: The human T-cell transcription factor-4 gene: Structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res 60: 3872–3879, 2000
Hovanes K, Li TWH, Waterman ML: The human LEF-1 gene contains a promoter preferentiallyactive in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res 28: 1994–2003, 2000
Brannon M, Brown JD, Bates R, Kimelman D, Moon RT: XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development 126: 3159–3170, 1999
Kumar V, Carlson JE, Ohgi KA, Edwards TA, Rose DW, Escalante CR, Rosenfeld MG, Aggarwal AK: Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. Mol Cell 10: 857–869, 2002
Kim GT, Shoda K, Tsuge T, Cho KH, Uchimiya H, Yokoyama R, Nishitani K, Tsukaya H: The ANGUSTI-FOLIA gene of Arabidopsis, a plant CtBP gene, regulates leaf-cell expansion, the arrangement of cortical microtubules in leaf cells and expression of a gene involved in cell-wall formation. EMBO J 21: 1267–1279, 2002
Folkers U, Kirik V, Schobinger U, Falk S, Krishnakumar S, Pollock MA, Oppenheimer DG, Day I, Reddy AS, Jurgens G, Hulskamp M, Reddy AR: The cell morphogenesis gene Angustifolia encodes a CtBP/BARS-like protein and is involved in the control of the microtubule cytoskeleton. EMBO J 21: 1280–1288, 2002
Zhang Q, Piston DW, Goodman RH: Regulation of corepressor function by nuclear NADH. Science 295: 1895–1897, 2002
Hecht A, Stemmler MP: Identification of a promoter-specific transcriptional activation domain at the C terminus of the Wnt effector protein T-cell factor 4. J Biol Chem 278: 3776–3785, 2003
Atcha FA, Munguia JE, Li TW, Hovanes K, Waterman ML: A new beta-catenin dependent activation domain in T cell factor. J Biol Chem 2003
Giese K, Kingsley C, Kirshner JR, Grosschedl R: Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev 9: 995–1008, 1995
Grosschedl R, Giese K, Pagel J: HMG domain proteins: Architectural elements in the assembly of nucleoprotein structures. Trends Genet 10: 94–100, 1994
Brantjes H, Roose J, van De Wetering M, Clevers H: All TCF HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 29: 1410–1419, 2001
Billin AN, Thirlwell H, Ayer DE: Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator. Mol Cell Biol 20: 6882–6890, 2000
Bruhn L, Munnerly A, Grosschedl R: ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCR alpha enhancer function. Genes Dev 11: 640–653, 1997
Giese K, Grosschedl R: LEF-1 contains an activation domain that stimulates transcription onlyin a specific context of factor-binding sites. EMBO J 12: 4667–4676, 1993
Carlsson P, Waterman M, Jones K: The hLEF/TCF-1a HMG protein contains a context-dependent transcriptional activation domain that induces the TCRa enhancer in T cells. Genes Dev 7: 2418–2430, 1993
Mayall TP, Sheridan PL, Montminy MR, KA J: Distinct Roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates In Vitro. Genes and Dev 11: 887–899, 1997
Castrop J, van Wichen D, Koomans-Bitter M, van de Wetering M, de Weger R, van Dongen J, Clevers H: The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. Blood 86: 3050–3059, 1995
Korinek V, Barker N, Morin P, van Wichen D, de Weger R, Kinzler K, Vogelstein B, Clevers H: Constitutive transcriptional activation bya beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 275: 1784–1787, 1997
Mayer K, Hieronymus T, Castrop J, Clevers H, Ballhausen W: Ectopic activation of lymphoid high mobility groupbox transcription factor TCF-1 and overexpression in colorectal cancer cells. Int J Cancer 72: 625–630, 1997
van Genderen C, Okamura R, Farinas I, Quo R, Parslow T, Bruhn L, Grosschedl R: Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 8: 2691–2703, 1994
Wong MH, Huelsken J, Birchmeier W, Gordon JI: Selection of multipotent stem cells during morphogenesis of small intestinal crypts of Lieberkuhn is perturbed by stimulation of Lef-1/beta-catenin signaling. J Biol Chem 277: 15843–15850, 2002
Aberle H, Bauer A, Stappert J, Kispert A, Kemler R: Betacatenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797–3804, 1997